TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3893208

Group type: EXPERIMENTAL
Intervention: Epidural pethidine 50 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intramuscular pethidine 100 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Epidural bupivacaine 25 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Epidural pethidine 50 mg and Epidural bupivacaine 25 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 19
Study: 29787410

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nondexmedetomidine
Number of subjects: 80
Study: 29782696

Group type: EXPERIMENTAL
Intervention: Standard care plus two ultrasounds and referral for complications
Number of subjects: 47423

Group type: COMPARATOR
Intervention: Standard antenatal care (ANC)
Number of subjects: 47423
Study: 26249150

Group type: EXPERIMENTAL
Intervention: mechano-chemical ablation +2% Polidocanol liquid
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: mechano-chemical ablation +3% Polidocanol liquid
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: mechano-chemical ablation +1% Polidocanol microfoam
Number of subjects: 87
Study: 25207547

Group type: EXPERIMENTAL
Intervention: Test tablet (ambroxol 30 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Test capsule (ambroxol 30 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference product (ambroxol 30 mg)
Number of subjects: 24
Study: 24617028

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (monthly consultations with primary care physician, weekly nutrition counseling for first 3 months, then monthly, and 12 group sessions in behavioral change protocol)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (monthly consultations with primary care physician)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 19512945

Group type: EXPERIMENTAL
Intervention: Theory-guided nursing intervention delivered by home health nurses via telephone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 18052950

Group type: EXPERIMENTAL
Intervention: Topiramate 25 mg per day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg per day
Number of subjects: 14
Study: 16214437

Group type: EXPERIMENTAL
Intervention: GIK infusion (25% glucose, 50 IU of soluble insulin per liter, and 80 mmol of potassium chloride per liter at 1 ml/kg/hour over 24 hours)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: GIK infusion
Number of subjects: 120
Study: 12404671

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761 (180 mg/day)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 10096258

Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxacin (400 mg twice a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Norfloxacin
Number of subjects: 12
Study: 7780277

Group type: EXPERIMENTAL
Intervention: Dapiprazole eye drops
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2086421

Group type: EXPERIMENTAL
Intervention: Modified O'Brien block
Number of subjects: 32

Group type: COMPARATOR
Intervention: Modified van Lint block
Number of subjects: 32

Group type: COMPARATOR
Intervention: Atkinson block
Number of subjects: 32
Study: 29271282

Group type: EXPERIMENTAL
Intervention: Caregiver Workstation condition (n = 35)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control condition (n = 36)
Number of subjects: 71
Study: 28557022

Group type: EXPERIMENTAL
Intervention: Unadjusted cluster-level analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline covariate-adjusted cluster-level analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random effects logistic regression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalised estimating equations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complete records analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multilevel multiple imputation
Number of subjects: 0
Study: 26323511

Group type: EXPERIMENTAL
Intervention: Intramuscular Haloperidol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intramuscular Midazolam
Number of subjects: 10
Study: 23721797

Group type: EXPERIMENTAL
Intervention: Exercise program with knee stabilization training
Number of subjects: 159

Group type: COMPARATOR
Intervention: Exercise program focusing on muscle strength and daily activities only (Control)
Number of subjects: 159
Study: 21784190

Group type: EXPERIMENTAL
Intervention: Eldecalcitol (0.75 μg daily)
Number of subjects: 1054
Study: 19254604

Group type: EXPERIMENTAL
Intervention: Moderate intensity, shorter duration (MISD) exercise
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Low-intensity, longer duration (LILD) exercise
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional therapeutic exercise (TE)
Number of subjects: 55
Study: 16707748

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 2006

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2006
Study: 14996859

Group type: EXPERIMENTAL
Intervention: Mastectomy with chemotherapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Mastectomy without chemotherapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Lumpectomy with chemotherapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Lumpectomy without chemotherapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 558

Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 558
Study: 11318765

Group type: EXPERIMENTAL
Intervention: Ondansetron (16 mg i.v.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9455272

Group type: EXPERIMENTAL
Intervention: Cellulose-based fibre dressing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ribbon gauze
Number of subjects: 40
Study: 7934351

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 1011
Study: 3360055

Group type: EXPERIMENTAL
Intervention: Trazodone (controlled-release formulation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Trazodone (conventional formulation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29154689

Group type: EXPERIMENTAL
Intervention: Non-invasive vagal nerve stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 10
Study: 27522346

Group type: EXPERIMENTAL
Intervention: Practice Only (PO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-Observation (SO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Expert Observation (EO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study: 25896965

Group type: EXPERIMENTAL
Intervention: 200mg mifepristone followed by 400 μg buccal misoprostol every 3 hours until complete fetal and placental expulsion (maximum 10 doses)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo followed by 400 μg buccal misoprostol every 3 hours until complete fetal and placental expulsion (maximum 10 doses)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 200mg mifepristone followed by 400 μg buccal misoprostol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo followed by 400 μg buccal misoprostol
Number of subjects: 120
Study: 23668248

Group type: EXPERIMENTAL
Intervention: Peer instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Faculty instruction
Number of subjects: 0
Study: 20684442

Group type: EXPERIMENTAL
Intervention: Visible dental decay (central position of caries)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Visible dental decay (presence of decay)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Visible dental decay (twice the amount of decay)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no visible decay)
Number of subjects: 100
Study: 19052336

Group type: EXPERIMENTAL
Intervention: Treated nets (lambdacyhalothrin 2.5 CS at 10 mg (a.i.)/m(2))
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Untreated nets
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Treated nets
Number of subjects: 1500
Study: 16466494

Group type: EXPERIMENTAL
Intervention: Approach 1 (specified adverse effects) + floating subheadings + text words for 'adverse effects' in MEDLINE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Approach 1 (specified adverse effects) + text words for 'adverse effects' in EMBASE
Number of subjects: 0
Study: 14610432

Group type: EXPERIMENTAL
Intervention: Enhanced education group (EEG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional education group (CEG)
Number of subjects: 25
Study: 11075307

Group type: EXPERIMENTAL
Intervention: Inhaled cyclosporin A (ADI628) 10 mg single dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled cyclosporin A (ADI628) 20 mg dose group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled cyclosporin A (ADI628) 10 mg bid (highest steady-state dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated inhaled doses of ADI628
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral cyclosporin A (3 mg/kg)
Number of subjects: 0
Study: 9025127

Group type: EXPERIMENTAL
Intervention: ACD-CPR
Number of subjects: 152

Group type: COMPARATOR
Intervention: STD-CPR
Number of subjects: 152
Study: 1679981

Group type: EXPERIMENTAL
Intervention: Salmeterol MDI (50 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salmeterol DPI (50 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol (200 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salmeterol MDI and DPI
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salmeterol MDI (2.21 mumol)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salmeterol DPI (1.88 mumol)
Number of subjects: 12
Study: 6839003

Group type: EXPERIMENTAL
Intervention: Theobid (260 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Theo-Dur (200 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Choledyl (128 mg)
Number of subjects: 9
Study: 31635890

Group type: EXPERIMENTAL
Intervention: Riluzole oral suspension 50 mg/10 mL via nasogastric tube
Number of subjects: 32

Group type: COMPARATOR
Intervention: Riluzole oral suspension 50 mg/10 mL orally
Number of subjects: 32
Study: 30630793

Group type: EXPERIMENTAL
Intervention: Combined therapy of methotrexate and immune adsorption
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 56
Study: 26511959

Group type: EXPERIMENTAL
Intervention: Praziquantel (total dose 60 mg/kg given as two split doses)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Praziquantel
Number of subjects: 370
Study: 24858669

Group type: EXPERIMENTAL
Intervention: M Technique intervention (7‐minute session, 6 times per week for 5 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: M Technique intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard NICU care
Number of subjects: 20
Study: 22597706

Group type: EXPERIMENTAL
Intervention: Standard admission orders
Number of subjects: 5338

Group type: EXPERIMENTAL
Intervention: Composite process-of-care measure
Number of subjects: 5338
Study: 20488274

Group type: EXPERIMENTAL
Intervention: Dietary counseling
Number of subjects: 563

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Both groups (dietary counseling and control)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Long-term awareness of hyperlipidemia
Number of subjects: 563
Study: 18926131

Group type: EXPERIMENTAL
Intervention: Placebo and exercise (1-hour cycling bout per day at 65%-70% of heart rate reserve)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Calcium supplementation and exercise (800 mg calcium supplementation and 1-hour cycling bout per day at 65%-70% of heart rate reserve)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo and no exercise
Number of subjects: 26
Study: 17197376

Group type: EXPERIMENTAL
Intervention: saquinavir/ritonavir/didanosine/lamivudine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: nelfinavir/didanosine/stavudine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: efavirenz/lamivudine/zidovudine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 12
Study: 12621132

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg per day
Number of subjects: 635

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 635
Study: 10554512

Group type: EXPERIMENTAL
Intervention: Home i.v. treatment (HIT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: In-patient treatment (SIT)
Number of subjects: 45
Study: 9772588

Group type: EXPERIMENTAL
Intervention: Beneficial Mixture for Body Immune Function (BMBIF)
Number of subjects: 20
Study: 1928766

Group type: EXPERIMENTAL
Intervention: Dopamine at a rate of 3 micrograms.kg‐1.min‐1 during surgery and the first postoperative 48 h
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dopamine (after excluding patients receiving mannitol flush)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline (after excluding patients receiving mannitol flush, control group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups (Dopamine and Saline)
Number of subjects: 48
Study: 6350242

Group type: EXPERIMENTAL
Intervention: Mixed schedule irradiation (two neutron and three photon fractions per week)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard photon irradiation
Number of subjects: 95
Study: 29193247

Group type: EXPERIMENTAL
Intervention: Advair® 100/50
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Advair® 250/50
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Advair® 500/50
Number of subjects: 17
Study: 27903009

Group type: EXPERIMENTAL
Intervention: Continuous cold flow device (Hilotherm, Hilotherm GmbH, Germany)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Crushed ice packs (control group)
Number of subjects: 50
Study: 26159147

Group type: EXPERIMENTAL
Intervention: Wheel of Wellness counseling intervention (n=49)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no treatment, n=44)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Wheel of Wellness counseling intervention (n=43)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (n=46)
Number of subjects: 93
Study: 23158114

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21636098

Group type: EXPERIMENTAL
Intervention: Tropicamide 0.3mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tropicamide 1mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tropicamide 3mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 18281786

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.75% with botulinum toxin A
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline with botulinum toxin A
Number of subjects: 16
Study: 16928778

Group type: EXPERIMENTAL
Intervention: Real-time text (C-Print)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sign language interpreting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time text (C-Print) and Communication Access Real-Time Translation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time text, direct (signed) instruction, and both
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interpreting and interpreting plus real-time text
Number of subjects: 0
Study: 12665986

Group type: EXPERIMENTAL
Intervention: Chronic low-frequency stimulation (CLFS) of knee extensor and hamstring muscles, 10 weeks, 4 hours per day, 7 days per week.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation (control group, n=10) with no evoked contractions.
Number of subjects: 20
Study: 11737046

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IVIG) therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (placebo control)
Number of subjects: 40
Study: 9264419

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg twice daily
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Fluvastatin only
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 8509627

Group type: EXPERIMENTAL
Intervention: Recombinant interferon‐alpha 2a (6 MU, thrice weekly)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Recombinant or natural interferon‐alpha (3 MU, thrice weekly)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: 12-month schedule of interferon administration
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Interferon treatment
Number of subjects: 234
Study: 3540033

Group type: EXPERIMENTAL
Intervention: Ketoprofen 25 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 29792885

Group type: EXPERIMENTAL
Intervention: 20 IU intranasal vasopressin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Neutral control sounds
Number of subjects: 25
Study: 27458307

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus ipilimumab (10 mg/kg every 3 weeks for a total of four doses)
Number of subjects: 1132

Group type: COMPARATOR
Intervention: Chemotherapy plus placebo
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus ipilimumab (10 mg/kg)
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus ipilimumab
Number of subjects: 1132
Study: 24474619

Group type: EXPERIMENTAL
Intervention: TAP‐E(+) group (ropivacaine with epinephrine)
Number of subjects: 52

Group type: COMPARATOR
Intervention: TAP‐E(‐) group (ropivacaine without epinephrine)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: RSB‐E(+) group (ropivacaine with epinephrine)
Number of subjects: 52

Group type: COMPARATOR
Intervention: RSB‐E(‐) group (ropivacaine without epinephrine)
Number of subjects: 52
Study: 23430418

Group type: EXPERIMENTAL
Intervention: Cell saver
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cardiotomy suction system
Number of subjects: 57

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 57
Study: 21561371

Group type: EXPERIMENTAL
Intervention: Balance exercise program (60 min, two times a week for 8 weeks)
Number of subjects: 38
Study: 18287163

Group type: EXPERIMENTAL
Intervention: O-(beta-hydroxyethyl)-rutosides (HR) 1500 mg/d
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: O-(beta-hydroxyethyl)-rutosides (HR) 2 g/d
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no pharmacologic or compression treatment)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Elastic compression stockings only
Number of subjects: 4
Study: 16507350

Group type: EXPERIMENTAL
Intervention: Current atrial fibrillation (AF)
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Prior atrial fibrillation (AF)
Number of subjects: 14703

Group type: COMPARATOR
Intervention: No atrial fibrillation (AF)
Number of subjects: 14703
Study: 14668173

Group type: EXPERIMENTAL
Intervention: Multi-digit couplings
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single digit couplings
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 100

Group type: COMPARATOR
Intervention: Three age groups (18 to 40+ years old)
Number of subjects: 100
Study: 10956284

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 8836663

Group type: EXPERIMENTAL
Intervention: MR889, 500 mg b.i.d. for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MR889, 500 mg b.i.d. for 4 weeks (subset with short disease duration)
Number of subjects: 60
Study: 1531426

Group type: EXPERIMENTAL
Intervention: Low protein diet (450 patients)
Number of subjects: 890

Group type: COMPARATOR
Intervention: Control diet (440 patients)
Number of subjects: 890

Group type: COMPARATOR
Intervention: Low protein diet vs Control diet
Number of subjects: 890
Study: 3896179

Group type: EXPERIMENTAL
Intervention: Polysorbate 60
Number of subjects: 141

Group type: COMPARATOR
Intervention: Glycerin (Control)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Subject-reported new hair growth
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Measurements of new hair growth
Number of subjects: 141
Study: 31880632

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted spinal anesthesia
Number of subjects: 44

Group type: COMPARATOR
Intervention: Landmark-guided spinal anesthesia
Number of subjects: 44
Study: 29758153

Group type: EXPERIMENTAL
Intervention: 0.454% SnF2 dentifrice (Test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.76% sodium monofluorophosphate dentifrice (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both dentifrices
Number of subjects: 0
Study: 27472565

Group type: EXPERIMENTAL
Intervention: Intraligamentary (IL) anesthesia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Supraperiosteal (SP) anesthesia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CCDS-administered IL anesthesia
Number of subjects: 90
Study: 25410083

Group type: EXPERIMENTAL
Intervention: Manual therapy (manipulation) with supervised exercise regime
Number of subjects: 62

Group type: COMPARATOR
Intervention: Supervised exercise regime alone
Number of subjects: 62
Study: 22412149

Group type: EXPERIMENTAL
Intervention: Internet-based tailored education program for CRF, 12 weeks duration
Number of subjects: 273

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 273
Study: 19878101

Group type: EXPERIMENTAL
Intervention: 100 ml of 20% albumin
Number of subjects: 6

Group type: COMPARATOR
Intervention: 100 ml of Ringer's acetate solution
Number of subjects: 6